Clearance Summary
NORAPAD PLAIN; NORAPAD TA received FDA 510(k) clearance under submission number K014268, sponsored by Perlei Medical, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Neurology review panel. The statutory decision date of record is 2002-03-27.
- Submission: K014268
- Applicant / Sponsor: Perlei Medical, Inc.
- Clearance pathway: Traditional
- Review panel: Neurology
- Device class: Class II
- Regulation citation: 21 CFR 882.4700
- Decision date: 2002-03-27
Classification & Regulation
This clearance is catalogued under FDA product code HBA and 21 CFR 882.4700, within the Neurology review panel as a Class II device.